After decades of intensive research, a groundbreaking treatment for Alzheimer's disease has arrived. In July 2024, the U.S. Food and Drug Administration (FDA) approved Kisunla® (donanemab), an innovative immunotherapy that represents a significant step forward in the fight against this devastating condition. This marks the dawn of disease-modifying treatments that target the biological causes of Alzheimer's rather than just managing symptoms. What Makes Kisunla® Revolutionary

When thinking of heart failure, most of us imagine weakened hearts and trouble breathing—not lunch menus or frailty. But recent research...

Osteoporosis is a common bone disease that weakens bones, making them more likely to break—especially in postmenopausal women and men...

A new study from Vanderbilt University tracked 404 adults over the age of 60 for seven years to understand the impact of sedentary...

A recent study reveals that taxi drivers have a lower risk of dying from Alzheimer's disease compared to other professions.

Turmeric, a staple in South Asian cuisine, is renowned for its numerous health benefits. Its active compound, curcumin, possesses...

People with Alzheimer’s disease often experience changes in their sleep patterns, including difficulty falling asleep, frequent nighttime...

Grapes are delicious fruits that come in various colors, such as green, red, black, yellow, and pink. They can be eaten fresh, dried, or...

Have you ever wondered what motivates you to exercise? Is it the desire to lose weight, to improve your mood, to prevent diseases, or to...

What is the connection between breakfast and brain health? That is the question that two neurologists, Dr. Mona Bahouth and Dr. Laura...

Loneliness isn't simply about being alone, it is gaining recognition as a risk for health, a risk for heart disease, dementia, some...

Coffee's ability to boost alertness is commonly attributed to caffeine but a new study showed that caffeine can't take all the credit ....

New research suggests that napping may improve brain health. Starting with data from 378,932 study participants (mean age 57), ...

Sucralose is sold under the brand name Splenda and is also used as an ingredient in packaged foods and beverages. FDA says sucralose is...

Desulfovibrio is a genus of Gram-negative sulfate-reducing bacteria, which lives in anaerobic environment but also in animals and human...

Untreated hearing loss increases dementia risk in middle-aged and older adults, new research confirms. It shows that a 42% increased risk...

Exciting results from a study which involved 220 volunteers : if we lower the number of calories we eat by 25%, we can slow the pace we...

A new study showed that a Modified Atkins Diet (MAD) reduces seizure frequency in patients with drug-resistant epilepsy .This research...

A study based on more than 28,000 person during 20 years ( from 1994 to 2014)was done in Sweden. The aim of this study was to...

Lecanemab , an anti-amyloid beta protofibril antibody, was approved under the FDA's accelerated approval pathway. This treatment option...